A cis-acting sequence that permits EBV plasmid replication and maintenance in cells expressing EBNA-1 has been identified (27). This sequence, designated oriP, consists of two components (13), both of which are required for plasmid replication. EBNA-1 is required in trans to support oriPmediated plasmid replication. One of two oriP components, a family of repeated sequences (20 sequences of 30 bp each), acts as a transcriptional enhancer for heterologous promoters. The EBNA-1 protein is also required in trans to support this enhancer activity (12, 21) .
genome per cell, depending on the presence of the EBV-determined nuclear antigen 1 (EBNA-1) protein. We found that transfection of the EBV BZLF1 gene causes the disappearance of EBNA proteins on Western blots (immunoblots). On the basis of these results, we attempted to eliminate EBV plasmids in Raji cells by transfecting a BZLF1 plasmid. Among 33 clones that were cotransfected with a BZLF1 plasmid and a hygromycin B resistance plasmid and selected resistant for hygromycin B, 24 clones had decreased numbers of EBV plasmids, as revealed by the decrease in the intensity of the EBV band on Southern blots compared with that of nontransfected Raji cells.
Epstein-Barr virus (EBV), a human lymphotropic herpesvirus, is the causative agent of infectious mononucleosis and is associated with human malignancies such as Burkitt's lymphoma, nasopharyngeal carcinoma, opportunistic lymphoma in immunocompromised hosts, and some cases of Hodgkin's lymphoma. Cells of lymphoblastoid lines established from Burkitt's lymphoma tissues, from peripheral lymphocytes of EBV-seropositive donors, and after in vitro EBV infection of human or primate lymphocytes express EBV-determined nuclear antigen (EBNA) and contain multiple copies of the EBV genome (usually 1 to 100 copies per cell). Most or all of the EBV DNAs are present as supercoiled DNA plasmids of approximately 172,000 bp (reviewed in reference 5).
A cis-acting sequence that permits EBV plasmid replication and maintenance in cells expressing EBNA-1 has been identified (27) . This sequence, designated oriP, consists of two components (13) , both of which are required for plasmid replication. EBNA-1 is required in trans to support oriPmediated plasmid replication. One of two oriP components, a family of repeated sequences (20 sequences of 30 bp each), acts as a transcriptional enhancer for heterologous promoters. The EBNA-1 protein is also required in trans to support this enhancer activity (12, 21) .
During a study of gene expression after the shift from a latent to a lytic replicative cycle in latently EBV-infected cells, we found that transfection of an expression vector for the EBV gene BZLF1, which causes the disruption of EBV latency (3, 4, 6, 24) , decreases the expression of EBNAs. Since the maintenance of EBV plasmids in transformed cells is dependent on the presence of the EBNA-1 protein (27), we intended to eliminate EBV plasmids from EBV-infected cells by transfecting the BZLF1 gene.
We studied the Raji cell line (11) , an African Burkitt's lymphoma cell line which maintains a stable copy number of EBV genomes (approximately 45 copies per cell [20] (28) , for immunoreaction confirmed the disappearance of the EBNA-2 band after pLTR-Z transfection. In contrast, the intensity of the latent membrane protein (LMP) band that was detected by another monoclonal antibody, CS1-4 (15) , did not change after pLTR-Z transfection (Fig. 1B) . EBV antigen expression was also studied by indirect immunofluorescence tests at each cellular level (24 (7) . Northern blot analysis was carried out as described previously (24) . The blots show hybridization with probes from the BamHI K fragment (upper blot) and the 0-actin DNA (lower blot). ment with 12-O-tetradecanoylphorbol-13-acetate (TPA) and n-butyrate, even though the latter treatment induced a higher proportion of EA-positive cells (about 60%). The transfection of expression vectors for other EBV genes, such as BRLF1, BMLF1, and BNLF1, or the BamHI Z fragment cloned into pBR322 had no effect on the intensity of EBNA bands on immunoblotting. Northern (RNA) blot analysis indicated that the EBNA-1 mRNA decreased after pLTR-Z transfection (Fig. 1C) .
These results suggest that the BZLF1 protein downregulates the expression of EBNAs. EBNA transcription is driven by one of two promoters designated Cp and Wp within the BamHI C and BamHI W fragments, respectively (2, 14, 16, 19) . These two promoter regions were inserted upstream of the chloramphenicol acetyltransferase (CAT) gene in the pSVoCAT vector (17) (25) . After 48 h of transfection, cells were harvested for CAT assays (17) . The percentage of chroramphenicol acetylated is indicated below the lanes. Figure 2 shows copies are shown in Fig. 3 . The decreased numbers of EBV genomes in these clones were stable and did not change after 6 months of culture. Among these six clones, three retained transfected pLTR-Z DNA when studied with Southern blots probed with the BamHI Z fragment of EBV DNA (Table 1) . These three clones constitutively expressed EA and the BZLF1 protein in 30 to 40% of the cells when studied by immunofluorescence with a polyvalent human antiserum and (26) . The overexpression of the BZLF1 protein from strong heterologous promoters may be required for downregulation of EBNA expression.
In contrast to EBNA expression, LMP expression was not influenced by pLTR-Z transfection. This might be explained by the long half-life of the cytoskeletal form of LMP (on the order of 16 to 20 h [10] ) and/or by the fact that the LMP promoter is less responsive to BZLF1 transfection than are EBNA promoters, as indicated by a previous report (8) .
The BZLF1-induced decreases in EBNA mRNA and proteins as well as CAT expression from EBNA promoters suggest that these decreases are mediated by a transcriptional mechanism. Absolute proof of a transcriptional mechanism would require the use of nuclear run-on studies, which we have not yet performed.
In Raji cell clones that retained the transfected BZLF1 DNA, only 30 to 40% of cells were found to express the BZLF1 product and other EA components. Because the entrance into a lytic cycle is cytolytic, cell clones in which only a subset of cells entered a lytic cycle were probably selected.
It is most likely that the decrease in the copy number of EBV plasmids in pLTR-Z-transfected Raji cells resulted from the decrease in EBNA-1 expression in these cells, since EBV plasmid replication requires EBNA-1 to bind to oriP sequences (13, 27) . The transfection of the pLTR vector or the BamHI Z fragment cloned into pBR322 had no effect on the copy numbers of EBV plasmids. The stable maintenance of decreased numbers of EBV genomes in pLTR-Z-transfected Raji cell clones, irrespective of the retention of transfected BZLF1 DNAs, suggests that the transient overexpression of the BZLF1 protein plays a major role in elimination of EBV genomes. The possibility that repeated transfections of the BZLF1 plasmid finally remove all of the EBV plasmids in Raji cells remains to be studied.
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